A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active-controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Trial Profile

A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active-controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Oliceridine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Acronyms APOLLO-1
  • Sponsors Trevena
  • Most Recent Events

    • 03 Aug 2017 According to a Trevena media release, data from the study has been presented at the 32nd Annual Meeting of the Society for Ambulatory Anesthesia (SAMBA).
    • 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society
    • 04 May 2017 According to a Trevena media release, data from this trial will be presented at the Society for Ambulatory Anesthesia (SAMBA) 32nd Annual Meeting, and at a sponsored symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top